Sign up for our complimentary
weekly e-journal

Main Newsletter
Mastery Series
Therapy Series
 
Bookmark and Share | Print Article | Test Your Knowledge Previous | All Articles This Week | Next
This article originally posted 10 October, 2006 and appeared in  Issue 333

Test Your Knowledge Issue 333

Symlin is a synthetic version of amylin, a hormone that is made in the beta cells of the pancreas and comes as an injection. The strength is 0.6mg/ml and the starting dose for Type 1 patients is 15mcg and for Type 2 patients the starting dose is 60mcg before each meal respectively.

Advertisement

When you instruct the patient to use Symlin in a 3/10 cc insulin syringe you would indicate the following starting amounts for Type 1 and Type 2 patients respectively before each meal:

1. 2.5 units and 10 units

2. 15 units and 60 units

3. 9 units and 36 units

4. 3 units and 27 units

For the correct answer, please click here.
Advertisement

 

Bookmark and Share | Print | Category | Home

This article originally posted 10 October, 2006 and appeared in  Issue 333

Past five issues: Diabetes Clinical Mastery Series Issue 85 | Issue 626 | Special Edition - Getting Patients on Track | Diabetes Clinical Mastery Series Issue 84 | Issue 625 |

 
Diabetes In Control Advertisers
 
 
Cast Your Vote
Now that once-weekly GLP-1 is available, which product are you recommending for your type 2 patients?

Navigate Diabetes In Control

Cardiovascular CE & CME Clinical Slides Drugs Affecting BG Safety Tools Test Your Knowledge Medications Polls Obesity Case Studies Jobs Interviews GLP-1 Agonist Sheri R. Colberg, PhD

Announcement:
 

Free Weekly Newsletter
Sign up here.

Free CE Available
CE Programs on diabetes




Search Articles On Diabetes In Control